Intelligent Oncology (ISSN 2950-2616), published by the KeAi Publishing Group quarterly as an open access (OA) publication and accessible via ScienceDirect, focuses on the cutting-edge discipline of intelligent oncology, which combines elements of artificial intelligence, and clinical oncology. Intelligent Oncology strives to become a leading platform for the advancement of this field.
This journal is steered by an elite group of physician-scientists,computer engineers,and cancer researchers, placing it in a leading position globally for the promulgation of the cutting-edge discipline of intelligent oncology. This new field merges elements of artificial intelligence and clinical oncology. The editorial board encompasses 40 seasoned professionals comprising physicians, scientists, and engineers.
Intelligent Oncology is an interdisciplinary scholastic journal that converges the fields of oncology and computer science, dedicated to publishing high-quality original research, review, commentary, etc. It serves as a platform to advance both theoretical and applied research integrating clinical oncology, information science, mathematics among other fields. Key topics include, but are not limited to, artificial intelligence technologies in oncology, innovative algorithms and medical interpretability, AI-assisted clinical trials,and guidelines and consensuses.
The Global Alliance for Intelligent Oncology (GAFIO), in its commitment to revolutionizing cancer care through the application of cutting-edge AI technology, it supports the publication of the Intelligent Oncology. This journal plays a crucial role in the advancement of intelligent oncology by providing a platform for the latest research findings, innovative approaches, and critical discussions within the field. Intelligent Oncology, with its focus on high-quality original research and reviews, is a key instrument in GAFIO's mission to foster an international ecosystem of intelligent oncology. By featuring pioneering studies and perspectives, the journal not only aligns with GAFIO's objectives but also contributes to the development of a global network that aims to enhance cancer treatment decisions.
Click here to go to the journal's official website.
